| 1/3 | US=33 / Câncer Koschmieder S, Tenen DG. Transcription factors in cancer stell cells of the hematopoietic lineage. In: Bagley RG, Teicher BA. Stem cells and cancer. New York: Humana Press, 2009. p. 75-83. ISBN 978-1-60327-932-1. CELULAS ESTAMINAIS HEMATOPOIETICAS; LEUCEMICAS DE CELULAS-TRONCO; TUMORAIS CELULAS ESTAMINAIS; LEUCEMIA MIELOIDE AGUDA; PU.1; CCAAT POTENCIADOR ALPHA PROTEINA DE LIGACAO |
| 2/3 | US=11 / Transplante Torlakovic EE, Naresh KN, Brunning RD. Other common markers. In: ___. Bone marrow immunohistochemistry. Chicago: American Society for Clinical Nutrition, 2009. p. 153-236. ISBN 978-0891895725. TRANSPLANTE; IMUNISTOQUIMICA; MEDULA OSSEA; MARCADORES; MIELOPEROXIDASE; HEMOGLOBINA A; HGBA; TRIPTASE DE MASTOCITOS; DESOXINUCLEOTIDIL TRANSFERASE TERMINAL; TDT; ANTIGENO RELACIONADO AO FATOR 8; FATOR DE VON WILLEBRAND; PAX-5; PU.1; FLI-1; CICLINA D1; LISOZIMA; BCL-6; IMUNOGLOBINAS; KI-67; MOLECULAS CITOTOXICAS; MARCADORES DE ESTROMA; MUM1; TRAP; BCL-2 |
| 3/3 | US=35 / Câncer Friedman AD. Molecular foundations of AML pathogenesis and physiology: aberrant transcription factors in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 27-42. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; FATORES DE TRANSCRICAO; RUNX1; C-MYB; MLL; HOXA9; WT1; EVI-1; C/EBPALFA; PU.1; RARALFA; GATA-1 |